Sharda Cropchem Limited (NSE:SHARDACROP)

India flag India · Delayed Price · Currency is INR
821.00
+1.00 (0.12%)
Jul 31, 2026, 3:29 PM IST
Market Cap73.96B -27.0%
Revenue (ttm)52.83B +16.9%
Net Income6.26B +49.1%
EPS69.40 +49.1%
Shares Out 90.22M
PE Ratio11.81
Forward PE10.83
Dividend18.00 (2.20%)
Ex-Dividend DateAug 7, 2026
Volume247,310
Open836.65
Previous Close820.00
Day's Range816.00 - 836.65
52-Week Range755.55 - 1,297.00
Beta0.60
AnalystsStrong Buy
Price Target1,204.17 (+46.67%)
Earnings DateJul 29, 2026

About Sharda Cropchem

Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth regulators, fumigants, regulators, rodenticides, metalaxyl, propiconazole, phenthoate, pendimethalin, and dithianon; and biocides. The company also provides conveyor belts, such as textile ply, rough top, steel cord, chevron/pattern, elevator, sidewall, pipe, and PVC/PVG solid woven conveyor belts, as we... [Read more]

Sector Materials
Founded 1987
Employees 500
Stock Exchange National Stock Exchange of India
Ticker Symbol SHARDACROP
Full Company Profile

Financial Performance

In fiscal year 2026, Sharda Cropchem's revenue was 52.68 billion, an increase of 21.94% compared to the previous year's 43.20 billion. Earnings were 6.81 billion, an increase of 123.69%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for SHARDACROP stock is "Strong Buy." The 12-month stock price target is ₹1,204, which is an increase of 46.67% from the latest price.

Price Target
₹1,204
(46.67% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Sharda Cropchem Transcript: Q1 26/27

Revenue grew 9% year-over-year with margin expansion, driven by NAFTA and LATAM growth and improved product mix, while Europe saw a temporary revenue dip but higher margins. Guidance for FY 2027 is maintained, with strong cash position and ongoing investment in registrations.

1 day ago - Transcripts

Sharda Cropchem Quarterly report: Q1 2027

Sharda Cropchem has published its Q1 2027 quarterly earnings report on July 30, 2026.

1 day ago - Filings

Sharda Cropchem Slides: Q1 2027

Sharda Cropchem has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on July 30, 2026.

1 day ago - Filings

Sharda Cropchem Transcript: Q4 25/26

Record FY 2026 results with 22% revenue and 124% PAT growth, driven by strong agrochemical performance and margin expansion. FY 2027 guidance targets 10%-15% revenue growth, 35% gross margin, and 18%-20% EBITDA margin, with robust liquidity and limited supply chain impact from global events.

2 months ago - Transcripts

Sharda Cropchem Quarterly report: Q4 2026

Sharda Cropchem has published its Q4 2026 quarterly earnings report on May 14, 2026.

2 months ago - Filings

Sharda Cropchem Slides: Q4 2026

Sharda Cropchem has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 14, 2026.

2 months ago - Filings

Sharda Cropchem Annual report: Q4 2026

Sharda Cropchem has published its Q4 2026 annual report on May 14, 2026.

2 months ago - Filings

Sharda Cropchem Transcript: Q3 25/26

Q3 FY 2026 saw 39% revenue growth and 366% PAT increase year-over-year, with strong volume gains and margin expansion. Guidance for FY 2027 includes 15-20% revenue growth, sustained gross margins, and continued high CapEx, supported by robust product registrations and a net debt-free position.

6 months ago - Transcripts

Sharda Cropchem Quarterly report: Q3 2026

Sharda Cropchem has published its Q3 2026 quarterly earnings report on January 30, 2026.

6 months ago - Filings

Sharda Cropchem Slides: Q3 2026

Sharda Cropchem has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 30, 2026.

6 months ago - Filings

Sharda Cropchem Transcript: Q2 25/26

Q2 FY26 saw 20% revenue growth and 35% volume growth, with gross margins up 690 bps to 34.5% and PAT up 75% year-on-year. Management expects strong H2 performance, maintaining EBITDA margin guidance of 15%-18% and robust cash reserves.

9 months ago - Transcripts

Sharda Cropchem Quarterly report: Q2 2026

Sharda Cropchem has published its Q2 2026 quarterly earnings report on October 31, 2025.

9 months ago - Filings

Sharda Cropchem Slides: Q2 2026

Sharda Cropchem has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on October 31, 2025.

9 months ago - Filings

Sharda Cropchem shares jump 5% today – Know More

Shares of Sharda Cropchem Ltd surged 4.60% to ₹1,020 on Tuesday, climbing nearly 5% intraday from the previous close of ₹975.10. The stock saw a sharp rally in afternoon trade, making it one of the no...

11 months ago - Business Upturn

Why are Sharda Cropchem shares up over 6% today? Explained

Shares of Sharda Cropchem rose sharply by 6.06% to Rs 963.85 in Wednesday’s trade after the company reported strong financial results for the quarter ended June 30, 2025. The stock gained Rs 55.10 fro...

1 year ago - Business Upturn

Sharda Cropchem Q1 results: Revenue up 26% YoY to Rs 958 crore, net profit jumps over 424%

Sharda Cropchem reported its Q1 Results, showcasing a sharp turnaround in profitability and healthy growth in revenue. The company posted a net profit of Rs 143 crore for the quarter ended June 30, 20...

1 year ago - Business Upturn

Sharda Cropchem shares surge 4.5% ahead of Q2 results

Sharda Cropchem shares surged by 4.5% today, trading at ₹781.05, ahead of its Q2 FY25 financial results announcement. The stock opened at ₹735.00 and reached an intraday high of ₹784.00, reflecting st...

1 year ago - Business Upturn